TOWARDS A MULTIMARKER MODEL OF CARDIOVASCULAR RISK – WHAT CAN POOLED ANALYSES OF CLINICAL AND GOVERNMENTAL DATABASES AND REGISTRIES PROVIDE IN AN ERA OF BIG DATA?